Jun 20, 2013
Off-Label Marketing Puts Novartis in Hot Water - Sold to Children
Off-Label Marketing Puts Novartis in Hot Water
By ROSE BOUBOUSHIAN
(CN) – Novartis Pharmaceuticals must face claims that it promoted the use on infants of a drug that U.S. regulators have deemed harmful, a federal judge ruled.
While…
View Post






